BTI
COLL icon

Blue Trust Inc’s Collegium Pharmaceutical COLL Stock Holding History

Blue Trust Inc’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.9K Sell
2,040
-30
-1% -$1.02K ﹤0.01% 1168
2026
Q1 		$68.5K Sell
2,070
-12
-0.6% -$508 ﹤0.01% 1197
2025
Q4 		$96.4K Sell
2,082
-6
-0.3% -$251 ﹤0.01% 1080
2025
Q3 		$73.1K Buy
2,088
+210
+11% +$7.3K ﹤0.01% 1216
2025
Q2 		$55.5K Buy
1,878
+134
+8% +$3.82K ﹤0.01% 1418
2025
Q1 		$52.1K Buy
1,744
+764
+78% +$23.3K ﹤0.01% 1339
2024
Q4 		$28.1K Sell
980
-96
-9% -$3.18K ﹤0.01% 1509
2024
Q3 		$34.6K Buy
1,076
+133
+14% +$4.74K ﹤0.01% 1719
2024
Q2 		$36.6K Buy
943
+122
+15% +$4.23K ﹤0.01% 1394
2024
Q1 		$31.9K Buy
821
+770
+1,510% +$26.9K ﹤0.01% 1072
2023
Q4 		$1K Buy
+51
New +$1.28K ﹤0.01% 2284

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Blue Trust Inc's COLL Position: Q2 2026 in Review

Blue Trust Inc reduced its Collegium Pharmaceutical (COLL) stake by 1.4% in Q2 2026, selling an estimated $1.02K and leaving 2,040 shares worth $73.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1168.

Blue Trust Inc first reported a position in COLL in Q4 2023 and has held it in 11 quarters since. The position peaked at $96.4K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Blue Trust Inc held 2,040 shares of Collegium Pharmaceutical worth $73.9K as of Q2 2026.
  • Blue Trust Inc sold 30 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.02K.
  • Collegium Pharmaceutical made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1168 holding.
  • Blue Trust Inc first reported a position in Collegium Pharmaceutical in Q4 2023 and has held it in 11 quarters since.
  • Blue Trust Inc's Collegium Pharmaceutical position peaked at $96.4K in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.